| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/14/2010 | EP2174660A1 Composition for mucosal administration containing agent for accelerating mucosal absorption of peptide drug and administration method thereof |
| 04/14/2010 | EP2174652A2 Oral pharmaceutical desmopressin composition |
| 04/14/2010 | EP2173890A1 Biological active proteins having increased in vivo and/or vitro stability |
| 04/14/2010 | EP2173876A2 T-cell cytokine-inducing surface molecules and methods of use |
| 04/14/2010 | EP2173868A1 Recombinant preparation of selected bromelain fractions |
| 04/14/2010 | EP2173773A1 Bifunctional fusion proteins of the alpha-melanocyte stimulating hormone (alpha-msh) and atrial natriuretic protein (anp) and uses in hypertension and acute kidney injury |
| 04/14/2010 | EP2173770A1 Method for removing endotoxin from proteins |
| 04/14/2010 | EP2173769A1 Process for purifying apyrogenic and virus-inactivated human hemoglobin |
| 04/14/2010 | EP2173373A2 Soluble her2 and her3 splice variant proteins, splice-switching oligonucleotides, and their use in the treatment of disease |
| 04/14/2010 | EP2173372A2 Novel peptides and protein and uses thereof |
| 04/14/2010 | EP2173371A1 Peptides derived from plasminogen activator inhibitor-1 and uses thereof |
| 04/14/2010 | EP2173365A2 Medicament for treating parkinson's disease |
| 04/14/2010 | EP2173364A1 Treating or preventing rotavirus infection |
| 04/14/2010 | EP2173325A1 Peptide slow-release formulations |
| 04/14/2010 | EP2173199A1 Food compositions |
| 04/14/2010 | EP1534751B1 Ocular gene therapy |
| 04/14/2010 | EP1440085B1 Transient immortalization of cells by oncogenic proteins or telomerase |
| 04/14/2010 | EP1409016B1 Antibodies to opgl |
| 04/14/2010 | EP1406928B1 Ntb-a, a surface molecule involved in natural killer cells activity |
| 04/14/2010 | EP1347773B1 Compositions and methods for enhancing cytokine activity and treating hypotension associated with the administration of cytokines |
| 04/14/2010 | EP1335901B1 Pharmaceutically active sulfanilide derivatives |
| 04/14/2010 | EP1305418B1 Human monoclonal antibody against hepatitis c virus e2 glycoprotein |
| 04/14/2010 | EP1294866B1 Use of acrp30 globular head to promote increases in muscle mass and muscle differentiation |
| 04/14/2010 | EP1237918B1 A gene, disrupted in schizophrenia |
| 04/14/2010 | EP1207199B1 Tumor antigen |
| 04/14/2010 | EP0964693B1 Novel bacteriocins, transport and vector system and method of use thereof |
| 04/14/2010 | EP0961833B1 Human plasma hyaluronidase |
| 04/14/2010 | EP0831903B1 Connective tissue growth factor |
| 04/14/2010 | CN1970570B Yeast engineered bacteria for expressing recombinant prawn protein Pen9 and its preparation method and uses |
| 04/14/2010 | CN1847260B Wheat germ protein depressor peptide desalting process |
| 04/14/2010 | CN1827763B Construction method for double-promoter yeast random peptide library for screening protein dissociation peptide |
| 04/14/2010 | CN1780638B Use of silicon oxide coated glass as inner wall material of coantainer and container having the inner wall of the material |
| 04/14/2010 | CN1777445B Agent for repairing corneal perception |
| 04/14/2010 | CN1465338B Skin activating composition for external used anti-aging preparation |
| 04/14/2010 | CN1360592B Streptogramin derivs., production thereof and composition containing same |
| 04/14/2010 | CN1346281B Use for preparing medicine used for the planned stimulation to controlled ovary |
| 04/14/2010 | CN101694497A Methods of delivery of exogenous proteins to the cytosol and uses thereof |
| 04/14/2010 | CN101693912A Recombinant plancenta hominis globin renaturation and medicine application protecting alcoholic hepatic injury thereof |
| 04/14/2010 | CN101693889A Design of beta-sheet proteins with specific binding properties |
| 04/14/2010 | CN101693888A Yellow mealworm plasmin and preparation method and applications thereof |
| 04/14/2010 | CN101693740A Homerl protein and application thereof in treating or preventing cerebral injury disease |
| 04/14/2010 | CN101693737A Cornu-like polypeptide with antioxidant activity, separation method and application thereof |
| 04/14/2010 | CN101693736A Novel peptides |
| 04/14/2010 | CN101693672A Peptidomimetic protease inhibitors |
| 04/14/2010 | CN101693111A Method for increasing entrapment rate of polylactic acid microspheres to water soluble protein |
| 04/14/2010 | CN101693108A Oral nutrition composition for beautifying skin |
| 04/14/2010 | CN101693107A Methods of treating neurological conditions with hematopoeitic growth factors |
| 04/14/2010 | CN101693106A Application of metallothionein on preparing medicines for treating diskal hernia and hyperosteogeny |
| 04/14/2010 | CN101693105A Application of IL-4-like recombinant protein of fishes |
| 04/14/2010 | CN101693104A New application of thymic peptide-5 |
| 04/14/2010 | CN101693103A Improvement of completeness of intestinal barrier |
| 04/14/2010 | CN101693016A Universal pharmaceutical formulation for recombined human serum albumin fusion proteins for injection |
| 04/14/2010 | CN101015580B PH-dependent composite bone peptide preparation, preparing method and use thereof |
| 04/13/2010 | US7696404 Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions |
| 04/13/2010 | US7696336 Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer |
| 04/13/2010 | US7696326 Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use thereof |
| 04/13/2010 | US7696325 Polypeptide inducing apoptosis |
| 04/13/2010 | US7696321 Molecules and methods for inhibiting shedding of KIM-1 |
| 04/13/2010 | US7696317 Mammalian genes; related reagents and methods |
| 04/13/2010 | US7696314 Hypoallergenic mutant polypeptides based on fish parvalbumin |
| 04/13/2010 | US7696313 Prodrug compounds with isoleucine |
| 04/13/2010 | US7696311 Generating peptide intermediate, incubating in dicloromethane, precipitating and recovering enfuvirtide; viricide; HIV fusion inhibitor |
| 04/13/2010 | US7696310 Peptides for detection of antibody to Anaplasma phagocytophilum |
| 04/13/2010 | US7696309 Membrane immobilized, protease resistant, cytokine for use in promoting tissue repair associated with cardiovascular, brain and ischemic injury |
| 04/13/2010 | US7696308 Fabricated in baculovirus; for penetration into human erythrocytes in event of infection; vaccines against malaria |
| 04/13/2010 | US7696307 inhibiting cell growth and metastasis and treat cancer ; A Disintegrin And Metalloproteinase with ThromboSpondin motifs (ADAMTS) |
| 04/13/2010 | US7696306 Compositions and methods for preventing or treating cancer |
| 04/13/2010 | US7696180 Antisense oligonucleotide derivative as antitumor agent; biodrugs |
| 04/13/2010 | US7696179 inhibiting HIV entry into CCR5-expressing cells; treatment and prevention of infectious diseases or disorders, e.g., HIV infection, AIDS, and AIDS-related diseases |
| 04/13/2010 | US7696176 Blood replacement product |
| 04/13/2010 | US7696175 Combination cancer immunotherapy with co-stimulatory molecules |
| 04/13/2010 | US7696174 Antimicrobial protein cecropin B, and exhibit cell stimulatory, migratory and antiinflammatory properties; preventing and reversing skin surface damage; wound healing include abrasions, blisters, burns, lacerations, ulcers, bruises, rashes, scars, and the effects of aging |
| 04/13/2010 | US7696173 fusion protein has trypsin and/or chymotrypsin loop being replaced with a vascular endothelial growth factor binding peptide; a culture product; anticarcinogenic agents, antitumor agents; antiinflammatory agent for treating cartilage and bone disorder; treating dermatitis |
| 04/13/2010 | US7696172 culture product produced by culturing a recombinant host cell under suitable conditions to express the polypeptide; has an oncogenic activity; treating liver disorder cirrhosis, or pancreas disorder |
| 04/13/2010 | US7696171 treating fibroblasts with the mutant FGF-1 polypeptides; promote tissue healing; greatly exceed the wild-type polypeptide in ability to stimulate human fibroblasts to proliferate; increase stability |
| 04/13/2010 | US7696170 Fibrosis inhibitor for implanted organ |
| 04/13/2010 | US7696169 Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents |
| 04/13/2010 | US7696168 Comprises transmembrane fusion proteins/protease activated (PAR)/chemokine/peptide receptor conjugated to cell penetrating moiety; antitumor/anticarcinogenic agents; antithrombin |
| 04/13/2010 | US7696167 Cyclic peptide compound |
| 04/13/2010 | US7696166 treating a mammal with hepatitis C; non-immunosuppressive |
| 04/13/2010 | US7696165 treating a mammal with hepatitis C; non-immunosuppressive |
| 04/13/2010 | US7696164 Substantially pure glycopeptide antibiotics AC-98-1 ; AC-98-2; AC-98-3; AC-98-4 and AC-98-5 |
| 04/13/2010 | US7696163 Forming a convalent conjugate of a peptide, EPO, removing X2 or a saccharyl subunit thereof from peptide forming a truncated glycan; contacting truncated glycan with glycosyltransferase and modified sugar donor under conditions suitable for glycosyltransferase to transfer a modified sugar moiety |
| 04/13/2010 | US7696162 Contains a surfactant and a preservative, an isotonicizing agent, a buffer, and/or an excipient; has less than 0.2% by weight of zinc based on the insulin content of the formulation; Polypeptide mixture; treating diabetes |
| 04/13/2010 | US7696161 Exendin agonist compounds |
| 04/13/2010 | US7696158 Use of IL-22 for the treatment of conditions of metabolic disorders |
| 04/13/2010 | US7696157 Plurality of isolated erythropoietin-like molecules; reperfusion injuries; antiischemic, antihypoxic, antiinflammatory gents; neurodegenerative or nervous system disorders; genetic engineering and expression |
| 04/13/2010 | US7696156 Human hemojuvelin (HJV) or dragon-like 1 (DL-1) polypeptides and variants and uses thereof |
| 04/13/2010 | US7696155 Hemojuvelin or dragon-like 2 (DL-2) polypeptides and variants and uses thereof |
| 04/13/2010 | US7696154 Administering formulation comprising polypeptide and muteins, fused proteins, muteins, functional derivatives and active fragments for treating autoimmune diseases, Type I diabetes, rheumatoid arthritis, graft rejections, inflammatory bowel disease, sepsis, multiple sclerosis, ischemic heart disease etc. |
| 04/13/2010 | US7696153 G-CSF conjugates |
| 04/13/2010 | US7696152 For modulating immune activity, hepatitis infections, the extent of nephritis, and the growth of a cancer |
| 04/13/2010 | US7696151 Providing a screening assay having stearoyl-CoA desaturase biological activity, contacting sceening assay with a test compound and measuring the biological activity |
| 04/13/2010 | US7696150 Nucleotide sequences coding interleukin receptor (EV127) for use in identifying modulators for and treatment of cell proliferative disorders; cancer diagnostic and treatments |
| 04/13/2010 | US7696149 Peptides present in form of acetate, gluconate, glucuronate, lactate, citrate, ascorbate, benzoate or phosphate salts and administration forms also contain one of above acids as free acids; for treating sex hormone-dependent diseases |
| 04/13/2010 | US7695959 Delivering an adeno-associated virus vector comprising a nucleotide sequence encoding glutamic acid decarboxylase to cells in specific areas of the brain; Parkinson's Disease, Alzheimer's Disease, Amyloid Lateral Sclerosis, and epilepsy |
| 04/13/2010 | US7695940 Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics |
| 04/13/2010 | US7695936 Knobs and holes heteromeric polypeptides |
| 04/13/2010 | US7695935 Using modified blood coagulation factor as therapeutic treatment for blood disorders and excessive bleeding due to tissue damage or trauma |
| 04/13/2010 | US7695934 Pure polypeptide containing a fragment capable of binding to and inducing apoptosis in a carcinoma cell; Tumor Necrosis Factor Related ligand "TRELL; gene therapy to treat tumors, autoimmune and inflammatory diseases or inherited genetic disorders |